Gene profile of Chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Liang, Yue jin ^a   Luo, Jie ^a   Lu, Qiao ^a   Zhou, Ying ^a   Wu, Hai wei ^b   Zheng, Dan ^a   Ren, Yong ya ^a   Sun, Ke yi ^a   Wang, Yong ^a   Zhang, Zhao song ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; PRAZIQUANTEL; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARENCHYMA; PROTEIN EXPRESSION; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; STELLATE CELL; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; CHEMOKINE CXCL10; CHEMOKINE CXCL11; CHEMOKINE CXCL9; CHEMOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HEPATIC STELLATE CELLS; HUMANS; LIVER; MICE; MICE, INBRED BALB C; PLATELET FACTOR 4; PRAZIQUANTEL; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS;

MUS; SCHISTOSOMA; SCHISTOSOMA JAPONICUM;

EID: 84864643840     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042490     Document Type: Article

References (42)

1. Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, et al. (2007) Immunopathology of schistosomiasis. Immunol Cell Biol 85: 148-154.
2. Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK, et al. (2009) Immunopathogenesis of human schistosomiasis. Parasite Immunol 31: 163-176.
3. Friedman SL, (2008) Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
4. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, et al. (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134: 657-667.
5. Friedman SL, (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
6. Wasmuth HE, Tacke F, Trautwein C, (2010) Chemokines in liver inflammation and fibrosis. Semin Liver Dis 30: 215-225.
7. Karlmark KR, Wasmuth HE, Trautwein C, Tacke F, (2008) Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev Gastroenterol Hepatol 2: 233-242.
8. Osterreicher CH, Taura K, De Minicis S, Seki E, Penz-Osterreicher M, et al. (2009) Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. Hepatology 50: 929-938.
9. Bonacchi A, Petrai I, Defranco RM, Lazzeri E, Annunziato F, et al. (2003) The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. Gastroenterology. 125: 1060-1076.
10. Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, et al. (2009) Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. Gastroenterology 137: 309-319, 319 e301-303.
11. Hong F, Tuyama A, Lee TF, Loke J, Agarwal R, et al. (2009) Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology 49: 2055-2067.
12. Anthony B, Mathieson W, de Castro-Borges W, Allen J, (2010) Schistosoma mansoni: egg-induced downregulation of hepatic stellate cell activation and fibrogenesis. Exp Parasitol 124: 409-420.
13. Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, et al. (2011) New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One 6: e20247.
14. Tao FF, Yang YF, Wang H, Sun XJ, Luo J, et al. (2009) Th1-type epitopes-based cocktail PDDV attenuates hepatic fibrosis in C57BL/6 mice with chronic Schistosoma japonicum infection. Vaccine 27: 4110-4117.
15. Weiskirchen R, Gressner AM, (2005) Isolation and culture of hepatic stellate cells. Methods Mol Med 117: 99-113.
16. Peterson TC, Rowden G, (1998) Drug-metabolizing enzymes in rat liver myofibroblasts. Biochem Pharmacol 55: 703-708.
17. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, et al. (1998) Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 115: 421-432.
18. Shimizu I, Mizobuchi Y, Yasuda M, Shiba M, Ma YR, et al. (1999) Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut 44: 127-136.
19. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, et al. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142-151.
20. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
21. Marra F, (2002) Chemokines in liver inflammation and fibrosis. Front Biosci 7: d1899-1914.
22. Wasmuth HE, Weiskirchen R, (2010) Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines. Z Gastroenterol 48: 38-45.
23. Bonacchi A, Romagnani P, Romanelli RG, Efsen E, Annunziato F, et al. (2001) Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 276: 9945-9954.
24. Perney P, Turriere C, Portales P, Rigole H, Psomas C, et al. (2009) CXCR3 expression on peripheral CD4+ T cells as a predictive marker of response to treatment in chronic hepatitis C. Clin Immunol. 132: 55-62.
25. Santodomingo-Garzon T, Han J, Le T, Yang Y, Swain MG, (2009) Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 49: 1267-1276.
26. Hasegawa H, Inoue A, Kohno M, Lei J, Miyazaki T, et al. (2008) Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model. Gene Ther 15: 171-182.
27. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C, et al. (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37: 1043-1055.
28. Morais CN, Carvalho BM, Melo WG, Lopes EP, Domingues AL, et al. (2006) Preliminar evaluation of cytokines in the hepatitis C-schistosomiasis co-infection. Mem Inst Oswaldo Cruz 101 Suppl 1: 353-354.
29. Pearce EJ, MacDonald AS, (2002) The immunobiology of schistosomiasis. Nat Rev Immunol 2: 499-511.
30. Bourd-Boittin K, Basset L, Bonnier D, L'Helgoualc'h A, Samson M, et al. (2009) CX3CL1/fractalkine shedding by human hepatic stellate cells: contribution to chronic inflammation in the liver. J Cell Mol Med 13: 1526-1535.
31. Aoyama T, Inokuchi S, Brenner DA, Seki E, (2010) CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52: 1390-1400.
32. Efsen E, Grappone C, DeFranco RM, Milani S, Romanelli RG, et al. (2002) Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans. J Hepatol 37: 39-47.
33. Zeremski M, Dimova R, Brown Q, Jacobson IM, Markatou M, et al. (2009) Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J Infect Dis 200: 1774-1780.
34. Hintermann E, Bayer M, Pfeilschifter JM, Luster AD, Christen U, (2010) CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation. J Autoimmun 35: 424-435.
35. Graves DT, Jiang YL, Williamson MJ, Valente AJ, (1989) Identification of monocyte chemotactic activity produced by malignant cells. Science 245: 1490-1493.
36. Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, et al. (2004) Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 31: 395-404.
37. Nakaya I, Wada T, Furuichi K, Sakai N, Kitagawa K, et al. (2007) Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. Nephron Exp Nephrol 107: e12-21.
38. Garcia-Lopez MA, Sanchez-Madrid F, Rodriguez-Frade JM, Mellado M, Acevedo A, et al. (2001) CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells. Lab Invest 81: 409-418.
39. Booth V, Clark-Lewis I, Sykes BD, (2004) NMR structure of CXCR3 binding chemokine CXCL11 (ITAC). Protein Sci 13: 2022-2028.
40. Campanella GS, Colvin RA, Luster AD, (2010) CXCL10 can inhibit endothelial cell proliferation independently of CXCR3. PLoS One 5: e12700.
41. Burke ML, McManus DP, Ramm GA, Duke M, Li Y, et al. (2010) Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl Trop Dis 4: e598.
42. Rutitzky LI, Hernandez HJ, Stadecker MJ, (2001) Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc Natl Acad Sci U S A 98: 13243-13248.